{"protocolSection":{"identificationModule":{"nctId":"NCT04310306","orgStudyIdInfo":{"id":"4-2019-1057"},"organization":{"fullName":"Yonsei University","class":"OTHER"},"briefTitle":"First-pass Recanalization With EmboTrap II in Acute Ischemic Stroke (FREE-AIS)","officialTitle":"First-pass Recanalization With EmboTrap II in Acute Ischemic Stroke (FREE-AIS)"},"statusModule":{"statusVerifiedDate":"2020-03","overallStatus":"UNKNOWN","lastKnownStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2020-02-10","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2021-12-30","type":"ESTIMATED"},"completionDateStruct":{"date":"2021-12-30","type":"ESTIMATED"},"studyFirstSubmitDate":"2020-03-13","studyFirstSubmitQcDate":"2020-03-13","studyFirstPostDateStruct":{"date":"2020-03-17","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-03-13","lastUpdatePostDateStruct":{"date":"2020-03-17","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Yonsei University","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This study is a prospective, open-label, multi-center, registry study, designed to to documents that EmboTrap II usage as a thrombectomy device for emergency large vessel occlusion (ELVO) in terms of the rate of First Pass Recanalization (FPR). Patients with ELVO will initially underwent mechanical thrombectomy usig EmboTrap II. FPR is defined as modified Tissue Thrombolysis In Cerebral Ischemia (mTICI) 2b or 3"},"conditionsModule":{"conditions":["Acute Ischemic Stroke Due to Intracranial Large Artery Occlusion"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":true,"targetDuration":"3 Months","designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":310,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Rescue stenting group","interventionNames":["Device: Thrombectomy using EmboTrap II"]}],"interventions":[{"type":"DEVICE","name":"Thrombectomy using EmboTrap II","description":"The subjects will receive endovascular treatment for acute stroke according to standard clinical practice. Specifically, using a stent retriever, contact aspiration EmboTrap II. The number of thrombectomy attempts is at the operator's discretion. Combination of balloon guide catheter or intermediate catheter is recommended.","armGroupLabels":["Rescue stenting group"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"First Pass Recanalization (FPR) rate","description":"The rate of FPR defined by modified TICI 2b or 3","timeFrame":"Within 1 day after the completion of endovascular thrombectomyh"}],"secondaryOutcomes":[{"measure":"The rate of modified Rankin scale 0-2 at 3 months after treatment","description":"The rate of modified Rankin Scale score (mRS), 0-2 at 90 days ± 14 days","timeFrame":"90 days ± 14 days"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Subjects experiencing acute ischemic stroke due to large vessel occlusion (intracranial internal carotid artery and middle cerebral artery M1 or proximal M2 segment, intracranial vertebral artery and basilar artery\n2. Age 19 or greater\n3. mRS before qualifying stroke, 0 to 2\n4. Baseline NIHSS score 4 or more\n5. CT ASPECTS \\> 5 or MR ASPECTS \\> 4\n6. Good collateral statues on CT angiogram (collateral grade by Calgary group, 4 or 5) or corresponding to DEFUSE 3 or DAWN trial on perfusion imaging.\n7. Onset (last-seen-well) time to femoral puncture time \\< 24 hours\n8. Anticipated life expectancy of at least 12 months\n9. Patients who undergo endovascular thrombectomy with EmboTrap II as the first-line device\n10. Signed informed consent for study enrollment\n\nExclusion Criteria:\n\n1. Multiple simultaneous large vessel occlusions\n2. Pregnancy\n3. Severe contrast allergy or absolute contraindication to iodinated contrast agent\n4. Patient has a severe or fatal combined illness that will prevent improvement of follow-up or will render the procedure unlikely to benefit the patient.","healthyVolunteers":false,"sex":"ALL","minimumAge":"19 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Patients with acute stroke due to ELVO within 24 hours after last seen well","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Byung Moon Kim, PhD","role":"CONTACT","phone":"82-2-2228-2399","email":"bmoon21@yuhs.ac"}],"locations":[{"facility":"Severance Hospital Stroke Center, Yonsei University College of Medicine","status":"RECRUITING","city":"Seongdu","country":"Korea, Republic of","contacts":[{"name":"Byung Moon Kim, PhD","role":"CONTACT","phone":"82-2-2228-2399","email":"bmoon21@yuhs.ac"}],"geoPoint":{"lat":37.02781,"lon":127.0473}}]},"ipdSharingStatementModule":{"ipdSharing":"UNDECIDED"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}